Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Thursday, April 18, 2024 | Back issues
Courthouse News Service Courthouse News Service

Shareholder Class Action

Trubion Pharmaceuticals is selling itself too cheaply through an unfair process to Emergent BioSolutions, for $4.55 a share plus 0.1641 shares of Emergent stock for each Trubion share, a $97 million deal, shareholders say in King County Court, Seattle.

Categories / Uncategorized

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...